Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 22, 2020
[USEFULNESS OF VIVID (VISUALIZATION OF VARIOUS INTEGRATION WITH DIFFUSION) ON COGNITIVE FUSION PROSTATE BIOPSY]Akira Ohtsu, Nobuaki Shimizu, Hiroyuki Horikoshi, et al.
Japanese Journal of Clinical Oncology|January 11, 2005
The role of radiotherapy for thymic carcinomaTetsuo Nonaka, Yoshio Tamaki, Keiko Higuchi, et al.
Anticancer Research|April 4, 2008
5-Fluorouracil-related gene expression in hepatic artery infusion-treated patients with hepatic metastases from colorectal carcinomasShinichi Sameshima, Shigeru Tomozawa, Hiroyuki Horikoshi, et al.
Annals of Nuclear Medicine|March 13, 2024
Flare phenomenon visualized by 99mTc-bone scintigraphy has prognostic value for patients with metastatic castration-resistant prostate cancerXue Zhang, Kenichi Nakajima, Atsushi Mizokami, et al.
Diagnostic Cytopathology|December 15, 2012
Immediate cytology improves accuracy and decreases complication rate in real-time computed tomography-guided needle lung biopsyKeisei Tachibana, Yoshimasa Nakazato, Shigeru Tsuchida, et al.
Anticancer Research|January 10, 2014
Early predictive value of non-response to docetaxel in neoadjuvant chemotherapy in breast cancer using 18F-FDG-PETTomoko Hirakata, Yasuhiro Yanagita, Tomomi Fujisawa, et al.
EJNMMI Research|December 28, 2013
Enhanced diagnostic accuracy for quantitative bone scan using an artificial neural network system: a Japanese multi-center database projectKenichi Nakajima, Yasuo Nakajima, Hiroyuki Horikoshi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 20, 2021
Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort studyKenichi Nakajima, Atsushi Mizokami, Hideyasu Matsuyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 7, 2022
Predictive factors for the effectiveness of novel androgen receptor axis-targeted agents in patients with metastatic prostate cancerNishimoto Koshiro, Kenichi Nakajima, Masafumi Oyama, et al.
Pageof 4